{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:12:43Z","timestamp":1793293963672,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.4065\/84.10.917","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T22:39:42Z","timestamp":1254436782000},"page":"917-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":327,"title":["Acute Coronary Syndromes: Diagnosis and Management, Part I"],"prefix":"10.4065","volume":"84","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.4065\/84.10.917_bib1","first-page":"480","article-title":"Heart disease and stroke statistics\u20142009 update. a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published correction appears in Circulation. 2009;119(3):e182]","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.4065\/84.10.917_bib2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/01.CIR.77.6.1213","article-title":"Insights into the pathogenesis of acute ischemic syndromes","volume":"77","author":"Fuster","year":"1988","journal-title":"Circulation"},{"issue":"5","key":"10.4065\/84.10.917_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (2)","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"10.4065\/84.10.917_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of the pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"10.4065\/84.10.917_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1749-6632.2001.tb03940.x","article-title":"New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo","volume":"947","author":"Corti","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.4065\/84.10.917_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00041433-200108000-00003","article-title":"Endothelial function and coronary artery disease","volume":"12","author":"Kinlay","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.4065\/84.10.917_bib7","doi-asserted-by":"crossref","first-page":"218A","DOI":"10.1016\/0735-1097(90)92590-X","article-title":"Myocardial infarction and coronary artery occlusion: a prospective 5-year angiographic study","volume":"15","author":"Webster","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.4065\/84.10.917_bib8","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.4065\/84.10.917_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes: implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/84.10.917_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"issue":"5","key":"10.4065\/84.10.917_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.69.5.377","article-title":"Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content","volume":"69","author":"Davies","year":"1993","journal-title":"Br Heart J"},{"issue":"19","key":"10.4065\/84.10.917_bib12","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.99.19.2503","article-title":"Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques","volume":"99","author":"Sukhova","year":"1999","journal-title":"Circulation"},{"issue":"16","key":"10.4065\/84.10.917_bib13","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/hc4101.097419","article-title":"Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling","volume":"104","author":"Herman","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.4065\/84.10.917_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.101.6.598","article-title":"Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study","volume":"101","author":"Schoenhagen","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/84.10.917_bib15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0735-1097(01)01234-7","article-title":"Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo","volume":"37","author":"von Birgelen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/84.10.917_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-134-3-200102060-00014","article-title":"Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences","volume":"134","author":"Rauch","year":"2001","journal-title":"Ann Intern Med"},{"issue":"3 (suppl)","key":"10.4065\/84.10.917_bib17","first-page":"II38","article-title":"A macro and micro view of coronary vascular insult in ischemic heart disease","volume":"82","author":"Davies","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/84.10.917_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0021-9150(91)90235-U","article-title":"Atherosclerotic plaque caps are locally weakened when macrophages density is increased","volume":"87","author":"Lendon","year":"1991","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.4065\/84.10.917_bib19","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jacc.2005.01.053","article-title":"Multiple plaque rupture and C-reactive protein in acute myocardial infarction","volume":"45","author":"Tanaka","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.4065\/84.10.917_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.CIR.0000079173.84669.4F","article-title":"C-reactive protein and lesion morphology in patients with acute myocardial infarction","volume":"108","author":"Sano","year":"2003","journal-title":"Circulation"},{"issue":"14","key":"10.4065\/84.10.917_bib21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"15","key":"10.4065\/84.10.917_bib22","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.4065\/84.10.917_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00041433-199608000-00010","article-title":"Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions","volume":"7","author":"L\u00fcscher","year":"1996","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.4065\/84.10.917_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0735-1097(96)00203-3","article-title":"Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris","volume":"28","author":"Chen","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.4065\/84.10.917_bib25","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1161\/01.CIR.94.12.3090","article-title":"Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes","volume":"94","author":"Moreno","year":"1996","journal-title":"Circulation"},{"key":"10.4065\/84.10.917_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/35097196","article-title":"Human genetics: to clot or not","volume":"413","author":"Fosang","year":"2001","journal-title":"Nature"},{"issue":"17","key":"10.4065\/84.10.917_bib27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","article-title":"A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis","volume":"334","author":"Weiss","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.10.917_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.4065\/84.10.917_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9149(73)80001-3","article-title":"Unstable angina pectoris: morbidity and mortality in 57 consecutive patients evaluated angiographically","volume":"32","author":"Conti","year":"1973","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.4065\/84.10.917_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM199201303260502","article-title":"Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes","volume":"326","author":"Mizuno","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.10.917_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.87.1.38","article-title":"Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit lesion in patients presenting with ischemic cardiac pain at rest: results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial","volume":"87","author":"The TIMI IIIA Investigators","year":"1993","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/84.10.917_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01061998","article-title":"Pathology of unstable angina: analysis of biopsies obtained by directional coronary atherectomy","volume":"1","author":"Sullivan","year":"1994","journal-title":"J Thromb Thrombolysis"},{"issue":"15","key":"10.4065\/84.10.917_bib33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198610093151501","article-title":"Coronary angioscopy in patients with unstable angina pectoris","volume":"315","author":"Sherman","year":"1986","journal-title":"N Engl J Med"},{"issue":"16","key":"10.4065\/84.10.917_bib34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM198010163031601","article-title":"Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction","volume":"303","author":"DeWood","year":"1980","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.10.917_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"issue":"17","key":"10.4065\/84.10.917_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin or both to treat unstable angina","volume":"319","author":"Th\u00e9roux","year":"1988","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.10.917_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.10.917_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators","year":"2001","journal-title":"N Engl J Med"},{"issue":"21","key":"10.4065\/84.10.917_bib39","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","author":"Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial Investigators","year":"1998","journal-title":"N Engl J Med"},{"issue":"25","key":"10.4065\/84.10.917_bib40","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.10.917_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00132404","article-title":"Time to reperfusion: the critical modulator in thrombolysis and primary angioplasty","volume":"3","author":"Cannon","year":"1996","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"10.4065\/84.10.917_bib42","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.4065\/84.10.917_bib43","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1001\/archinte.163.18.2157","article-title":"Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease","volume":"163","author":"McDermott","year":"2003","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.4065\/84.10.917_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1008876322599","article-title":"Clinical features of emergency department patients presenting with symptoms suggestive of acute cardiac ischemia: a multicenter study","volume":"6","author":"Pope","year":"1998","journal-title":"J Thromb Thrombolysis"},{"key":"10.4065\/84.10.917_bib45","series-title":"Unstable angina: diagnosis and management","author":"Braunwald","year":"1994"},{"issue":"18","key":"10.4065\/84.10.917_bib46","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa042741","article-title":"Prognostic significance of dyspnea in patients referred for cardiac stress testing","volume":"353","author":"Abidov","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.10.917_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-118-2-199301150-00001","article-title":"Value of the history and physical in identifying patients at increased risk for coronary artery disease","volume":"118","author":"Pryor","year":"1993","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.4065\/84.10.917_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-9343(97)00086-7","article-title":"Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease","volume":"102","author":"Morise","year":"1997","journal-title":"Am J Med"},{"issue":"6","key":"10.4065\/84.10.917_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0895-4356(92)90134-9","article-title":"Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study","volume":"45","author":"Jayes","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.4065\/84.10.917_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","article-title":"The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study","volume":"30","author":"Cannon","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.4065\/84.10.917_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","article-title":"Prognostic value of the admission electrocardiogram in acute coronary syndromes","volume":"281","author":"Savonitto","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/84.10.917_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0002-9149(99)00319-7","article-title":"Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression","volume":"84","author":"Hyde","year":"1999","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.4065\/84.10.917_bib53","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/oxfordjournals.eurheartj.a061728","article-title":"The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction","volume":"5","author":"Yusuf","year":"1984","journal-title":"Eur Heart J"},{"issue":"18","key":"10.4065\/84.10.917_bib54","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198505023121801","article-title":"Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction","volume":"312","author":"Brush","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.10.917_bib55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.90.1.613","article-title":"Diagnosing and managing unstable angina","volume":"90","author":"Braunwald","year":"1994","journal-title":"Circulation"},{"issue":"5","key":"10.4065\/84.10.917_bib56","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(96)00392-0","article-title":"ACC\/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)","volume":"28","author":"Ryan","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.4065\/84.10.917_bib57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/hc3801.096336","article-title":"Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I","volume":"104","author":"McCord","year":"2001","journal-title":"Circulation"},{"key":"10.4065\/84.10.917_bib58","series-title":"Mayo Clinic Cardiology: Concise Textbook","first-page":"773","article-title":"Cardiac biomarkers","author":"Shapiro","year":"2007"},{"issue":"suppl I","key":"10.4065\/84.10.917_bib59","first-page":"I433","article-title":"CHF on presentation is associated with markedly worse outcomes among patients with acute coronary syndromes: PURSUIT trial findings","volume":"100","author":"Jaber","year":"1999","journal-title":"Circulation"},{"issue":"19","key":"10.4065\/84.10.917_bib60","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.4065\/84.10.917_bib61","unstructured":"Batter A. The Euro Heart Survey of Acute Coronary Syndromes (EHSACS) Presented at: European Society of Cardiology Scientific Sessions. Stockholm, Sweden; Sept 1-5, 2001."},{"issue":"21","key":"10.4065\/84.10.917_bib62","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels","volume":"340","author":"Hamm","year":"1999","journal-title":"N Engl J Med"},{"issue":"9192","key":"10.4065\/84.10.917_bib63","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"issue":"9180","key":"10.4065\/84.10.917_bib64","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","author":"FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators","year":"1999","journal-title":"Lancet"},{"issue":"22","key":"10.4065\/84.10.917_bib65","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"issue":"20","key":"10.4065\/84.10.917_bib66","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.102.20.2466","volume":"102","author":"Th\u00e9roux","year":"2000","journal-title":"Circulation"},{"issue":"23","key":"10.4065\/84.10.917_bib67","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/hc4801.100029","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes","volume":"104","author":"Roffi","year":"2001","journal-title":"Circulation"},{"issue":"suppl A","key":"10.4065\/84.10.917_bib68","first-page":"410A","article-title":"Prior peripheral vascular disease and cerebrovascular disease are independent predictors of increased 1 year mortality in patients with acute coronary syndromes: results from OPUS-TIMI 16 [abstract]","volume":"35","author":"Cotter","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.4065\/84.10.917_bib69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1067\/mhj.2001.113994","article-title":"Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin","volume":"141","author":"Santopinto","year":"2001","journal-title":"Am Heart J"},{"issue":"10","key":"10.4065\/84.10.917_bib70","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0735-1097(02)01833-8","article-title":"Clinical value of 12-lead electrocardiography to predict the long-term prognosis of GISSI-1 patients","volume":"39","author":"Mauri","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.4065\/84.10.917_bib71","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"issue":"18","key":"10.4065\/84.10.917_bib72","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.10.917_bib73","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.4065\/84.10.917_bib74","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9149(00)01444-2","article-title":"Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris","volume":"87","author":"Cannon","year":"2001","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.4065\/84.10.917_bib75","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(02)02484-1","article-title":"Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 substudy","volume":"40","author":"Sabatine","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.4065\/84.10.917_bib76","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.4065\/84.10.917_bib77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"issue":"14","key":"10.4065\/84.10.917_bib78","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"de Lemos","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.10.917_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jacc.2004.04.033","article-title":"B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy","volume":"44","author":"Mega","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.4065\/84.10.917_bib80","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000176706","article-title":"Relationship between plasma level of brain natriuretic peptide and myocardial infarct size","volume":"85","author":"Arakawa","year":"1994","journal-title":"Cardiology"},{"issue":"15","key":"10.4065\/84.10.917_bib81","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"Sabatine","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.4065\/84.10.917_bib82","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.4065\/84.10.917_bib83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/euhj.2001.2738","article-title":"An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: application of the TIMI Risk Score for UA\/NSTEMI in PRISM-PLUS","volume":"23","author":"Morrow","year":"2002","journal-title":"Eur Heart J"},{"issue":"6","key":"10.4065\/84.10.917_bib84","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2006.05.056","article-title":"Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy","volume":"48","author":"James","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.4065\/84.10.917_bib85","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"issue":"19","key":"10.4065\/84.10.917_bib86","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"issue":"17","key":"10.4065\/84.10.917_bib87","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.4065\/84.10.917_bib88","first-page":"783","article-title":"Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction","volume":"44","author":"Wiviott","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9146","key":"10.4065\/84.10.917_bib89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"10.4065\/84.10.917_bib90","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter","year":"2005","journal-title":"N Engl J Med"},{"issue":"9564","key":"10.4065\/84.10.917_bib91","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(07)60410-3","article-title":"Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study","volume":"369","author":"Hirsch","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.4065\/84.10.917_bib92","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.4065\/84.10.917_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.300.1.71","article-title":"Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis","volume":"300","author":"O'Donoghue","year":"2008","journal-title":"JAMA"},{"issue":"21","key":"10.4065\/84.10.917_bib94","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.10.917_bib95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"Use of sildenafil (Viagra) in patients with cardiovascular disease","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.4065\/84.10.917_bib96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"10.4065\/84.10.917_bib97","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/84.10.917_bib98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-008-0264-4","article-title":"Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis","volume":"27","author":"Gibson","year":"2009","journal-title":"J Thromb Thrombolysis"},{"issue":"9497","key":"10.4065\/84.10.917_bib99","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.4065\/84.10.917_bib100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.73.2.331","article-title":"Effect of the addition of propranolol to therapy with nifedepine for unstable angina: a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Gottlieb","year":"1986","journal-title":"Circulation"},{"issue":"5","key":"10.4065\/84.10.917_bib101","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.56.5.400","article-title":"Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both","volume":"56","author":"The Holland Interuniversity Nifedipine\/Metoprolol Trial (HINT) Research Group","year":"1986","journal-title":"Br Heart J"},{"issue":"3","key":"10.4065\/84.10.917_bib102","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(85)80400-9","article-title":"A randomized study comparing propranolol and diltiazem in the treatment of unstable angina","volume":"5","author":"Th\u00e9roux","year":"1985","journal-title":"J Am Coll Cardiol"},{"issue":"suppl. II","key":"10.4065\/84.10.917_bib103","first-page":"II","article-title":"Immediate use of beta blockers, but not calcium blockers, improves prognosis in unstable angina [abstract]","volume":"84","author":"Rizik","year":"1991","journal-title":"Circulation"},{"issue":"7","key":"10.4065\/84.10.917_bib104","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","author":"The Multicenter Diltiazem Postinfarction Trial Research Group","year":"1988","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.10.917_bib105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/oxfordjournals.eurheartj.a061701","article-title":"Verapamil in acute myocardial infarction","volume":"5","author":"The Danish Study Group on Verapamil in Myocardial Infarction","year":"1984","journal-title":"Eur Heart J"},{"issue":"9","key":"10.4065\/84.10.917_bib106","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/clc.4960210906","article-title":"Verapamil use in patients with cardiovascular disease: an overview of randomized trials","volume":"21","author":"Pepine","year":"1998","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.4065\/84.10.917_bib107","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198608143150704","article-title":"Diltiazem and reinfarction in patients with non-Q wave myocardial infarction: results of a double-blind, randomized, multicenter trial","volume":"315","author":"Gibson","year":"1986","journal-title":"N Engl J Med"},{"issue":"6556","key":"10.4065\/84.10.917_bib108","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.293.6556.1204","article-title":"Trial of early nifedepine in acute myocardial infarction: the Trent study","volume":"293","author":"Wilcox","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"18","key":"10.4065\/84.10.917_bib109","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"issue":"23","key":"10.4065\/84.10.917_bib110","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"issue":"8951","key":"10.4065\/84.10.917_bib111","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction","volume":"345","year":"1995","journal-title":"Lancet"},{"issue":"8951","key":"10.4065\/84.10.917_bib112","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(95)90866-8","article-title":"Oral captopril versus placebo among 13,634 patients with suspected myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)","volume":"345","year":"1995","journal-title":"Lancet"},{"issue":"20","key":"10.4065\/84.10.917_bib113","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [published correction appears in N Engl J Med. 2004;350(2):203]","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.10.917_bib114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0735-1097(99)00146-1","article-title":"Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction","volume":"34","author":"Gustafsson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/84.10.917_bib115","first-page":"145","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000;342(18):1376 and 2000;342(10):748]","volume":"342","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"N Engl J Med"},{"issue":"14","key":"10.4065\/84.10.917_bib116","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [published correction appears in N Engl J Med. 2003 Apr 3;348(22):2271]","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.4065\/84.10.917_bib117","doi-asserted-by":"crossref","first-page":"1186.e1","DOI":"10.1016\/j.ahj.2006.01.004","article-title":"Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial","volume":"151","author":"Morrow","year":"2006","journal-title":"Am Heart J"},{"issue":"16","key":"10.4065\/84.10.917_bib118","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"issue":"22","key":"10.4065\/84.10.917_bib119","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina; results of a Canadian multicenter trial","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"issue":"8719","key":"10.4065\/84.10.917_bib120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","author":"RISC Group","year":"1990","journal-title":"Lancet"},{"issue":"24","key":"10.4065\/84.10.917_bib121","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1053\/euhj.2000.2474","article-title":"The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease","volume":"21","author":"CURE Study Investigators","year":"2000","journal-title":"Eur Heart J"},{"issue":"9281","key":"10.4065\/84.10.917_bib122","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.4065\/84.10.917_bib123","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.4065\/84.10.917_bib124","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2005.11.025","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.4065\/84.10.917_bib125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.4065\/84.10.917_bib126","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.CIR.0000138790.14877.7D","volume":"110","author":"Eagle","year":"2004","journal-title":"Circulation"},{"issue":"25","key":"10.4065\/84.10.917_bib127","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"issue":"20","key":"10.4065\/84.10.917_bib128","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.4065\/84.10.917_bib129","first-page":"361","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes. [epub before print.]","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"9302","key":"10.4065\/84.10.917_bib130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"issue":"14","key":"10.4065\/84.10.917_bib131","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/01.CIR.98.14.1358","article-title":"Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE)","volume":"98","author":"Klootwijk","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.4065\/84.10.917_bib132","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(99)00049-1","article-title":"Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes","volume":"83","author":"Alexander","year":"1999","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.4065\/84.10.917_bib133","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.4065\/84.10.917_bib134","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"issue":"5, pt 1","key":"10.4065\/84.10.917_bib135","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","article-title":"Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina","volume":"88","author":"Th\u00e9roux","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"10.4065\/84.10.917_bib136","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11239-006-9049-9","article-title":"Heparin resistance in acute coronary syndromes","volume":"23","author":"Rich","year":"2007","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"10.4065\/84.10.917_bib137","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.4065\/84.10.917_bib138","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"issue":"15","key":"10.4065\/84.10.917_bib139","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","article-title":"Assessment of the treatment effect of enoxaparin for unstable Angina\/Non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/84.10.917_bib140","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"issue":"19","key":"10.4065\/84.10.917_bib141","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.ehj.2004.06.028","article-title":"Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial","volume":"25","author":"de Lemos","year":"2004","journal-title":"Eur Heart J"},{"issue":"15","key":"10.4065\/84.10.917_bib142","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"issue":"suppl I","key":"10.4065\/84.10.917_bib143","first-page":"I372","article-title":"Elevated baseline myoglobin is associated with increased mortality in acute coronary syndromes, even among patients with normal baseline troponin I: a TIMI 11B substudy","volume":"100","author":"de Lemos","year":"1999","journal-title":"Circulation"},{"issue":"21","key":"10.4065\/84.10.917_bib144","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.4065\/84.10.917_bib145","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.10.917_bib146","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0735-1097(00)01118-9","article-title":"Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina","volume":"37","author":"Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"9327","key":"10.4065\/84.10.917_bib147","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"issue":"13","key":"10.4065\/84.10.917_bib148","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.10.917_bib149","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"19","key":"10.4065\/84.10.917_bib150","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"issue":"15","key":"10.4065\/84.10.917_bib151","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes [published correction appears in N Engl J Med. 2006;354(7):778]","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.10.917_bib152","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611605090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611605090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:42:51Z","timestamp":1706002971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611605090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":152,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0025619611605090"],"URL":"https:\/\/doi.org\/10.4065\/84.10.917","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Coronary Syndromes: Diagnosis and Management, Part I","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/84.10.917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}